Telemedicine strategy of the European Reference Network ITHACA for the diagnosis and management of patients with rare developmental disorders
Language English Country England, Great Britain Media electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
32334637
PubMed Central
PMC7183125
DOI
10.1186/s13023-020-1349-1
PII: 10.1186/s13023-020-1349-1
Knihovny.cz E-resources
- Keywords
- Developmental disorders, European reference network, Rare disease, Telemedicine,
- MeSH
- Child MeSH
- Humans MeSH
- Delivery of Health Care MeSH
- Telemedicine * MeSH
- Developmental Disabilities MeSH
- Rare Diseases * diagnosis therapy MeSH
- Check Tag
- Child MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Europe MeSH
BACKGROUND: The European Reference Networks, ERNs, are virtual networks for healthcare providers across Europe to collaborate and share expertise on complex or rare diseases and conditions. As part of the ERNs, the Clinical Patient Management System, CPMS, a secure digital platform, was developed to allow and facilitate web-based, clinical consultations between submitting clinicians and relevant international experts. The European Reference Network on Intellectual Disability, TeleHealth and Congenital Anomalies, ERN ITHACA, was formed to harness the clinical and diagnostic expertise in the sector of rare, multiple anomaly and/or intellectual disability syndromes, chromosome disorders and undiagnosed syndromic disorders. We present the first year results of CPMS use by ERN ITHACA as an example of a telemedicine strategy for the diagnosis and management of patients with rare developmental disorders. RESULTS: ERN ITHACA ranked third in telemedicine activity amongst 24 European networks after 12 months of using the CPMS. Information about 28 very rare cases from 13 different centres across 7 countries was shared on the platform, with diagnostic or other management queries. Early interaction with patient support groups identified data protection as of primary importance in adopting digital platforms for patient diagnosis and care. The first launch of the CPMS was built to accommodate the needs of all ERNs. The ERN ITHACA telemedicine process highlighted a need to customise the CPMS with network-specific requirements. The results of this effort should enhance the CPMS utility for telemedicine services and ERN-specific care outcomes. CONCLUSIONS: We present the results of a long and fruitful process of interaction between the ERN ITHACA network lead team and EU officials, software developers and members of 38 EU clinical genetics centres to organise and coordinate direct e-healthcare through a secure, digital platform. The variability of the queries in just the first 28 cases submitted to the ERN ITHACA CPMS is a fair representation of the complexity and rarity of the patients referred, but also proof of the sophisticated and variable service that could be provided through a structured telemedicine approach for patients and families with rare developmental disorders. Web-based approaches are likely to result in increased accessibility to clinical genomic services.
Department of Genetics AP HP Robert Debré University Hospital Bd Sérurier 75019 Paris France
Department of Medical Genetics CHU de Lyon 162 Avenue Lacassagne 69003 Lyon France
Department of Medical Genetics CHU de Rennes 2 rue Henri Le Guilloux 35033 Rennes cedex 9 France
Genetics and Rare Diseases Research Division Ospedale Pediatrico Bambino Gesù IRCCS 00146 Rome Italy
Open Applications Consulting Ltd Avoca House 191 Parnell St Rotunda Dublin 1 Ireland
Romanian National Alliance for Rare Diseases RONARD 29 Avram Iancu etaj 3 450143 Zalau Romania
Université Paris Diderot 5 Rue Thomas Mann 75013 Paris France
See more in PubMed
Teoli D Aeddula NR. Telemedicine. NCBI Books. https://www.ncbi.nlm.nih.gov/books/NBK535343/ Accessed 06 Feb 2020.
Brooks M. Feasibility of developing a pediatric telehealth network in Honduras with international consultation support. Rural Remote Health. 2017;17:3965. doi: 10.22605/RRH3965. PubMed DOI
Hopper B, Buckman M, Edwards M. Evaluation of satisfaction of parents with the use of videoconferencing for a pediatric genetic consultation. Twin Res Hum Genet. 2011;14:343–346. doi: 10.1375/twin.14.4.343. PubMed DOI
Kubendran S, Sivamurthy S, Schaefer GB. A novel approach in pediatric telegenetic services: geneticist, pediatrician and genetic counselor team. Genet Med. 2017;19:1260–1267. doi: 10.1038/gim.2017.45. PubMed DOI PMC
Hilgart JS, Hayward JA, Coles B, Iredale R. Telegenetics: a systematic review of telemedicine in genetics services. Genet Med. 2012;14:765–776. doi: 10.1038/gim.2012.40. PubMed DOI
Stalker HJ, Wilson R, McCune H, Gonzalez J, Moffett M, Zori RT. Telegenetic medicine: improved access to services in an underserved area. J Telemed Telecare. 2006;12:182–185. doi: 10.1258/135763306777488762. PubMed DOI
Stuckey R, Domingues-Montanari S. Telemedicine is helping the parents of children with neurodevelopmental disorders living in remote and deprived areas. Paediatr Int Child Health. 2017;37:3,155–3,157. doi: 10.1080/20469047.2017.1315914. PubMed DOI
Douzgou S, Clayton-Smith J, Gardner S, Day R, Griffiths P, Strong K, DYSCERNE expert panel Dysmorphology at a distance: results of a web-based diagnostic service. Eur J Hum Genet. 2014;22:327–332. doi: 10.1038/ejhg.2013.137. PubMed DOI PMC
Douzgou S, Pollalis YA, Vozikis A, Patrinos GP, Clayton-Smith J. Collaborative crowdsourcing for the diagnosis of rare genetic syndromes: the DYSCERNE experience. Public Health Genomics. 2016;19:19–24. doi: 10.1159/000440710. PubMed DOI
Douzgou S, Chervinsky E, Gyftodimou Y, et al. Dysmorphology services: a snapshot of current practices and a vision for the future. Clin Genet. 2016;89:27–33. doi: 10.1111/cge.12571. PubMed DOI
Héon-Klin V. European reference networks for rare diseases: what is the conceptual framework? Orphanet J Rare Dis. 2017;12:137. doi: 10.1186/s13023-017-0676-3. PubMed DOI PMC
OpenApp Evidence for Healthcare. https://www.openapp.ie/cpms-european-reference-networks-ern Accessed 04 Feb 2020.
Privacy Statement, European Reference Networks for Rare, Low Prevalence and Rare Diseases Clinical Patient Management System (CPMS). https://ec.europa.eu/health/sites/health/files/ern/docs/cpms_ps_en.pdf Accessed 06 Feb 2020.
Roland MO, Bartholomew J, Morrell DC, et al. Understanding hospital referral rates: a user's guide. BMJ. 1990;301:98–102. doi: 10.1136/bmj.301.6743.98. PubMed DOI PMC
Orphanet: an online database of rare diseases and orphan drugs. Copyright, INSERM 1997. http://www.orpha.net Accessed 04 Feb 2020.
Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University, Baltimore. https://omim.org/ Accessed 04 Feb 2020.
Delaigue S, Bonnardot L, Steichen O, et al. Seven years of telemedicine in Médecins Sans Frontières demonstrate that offering direct specialist expertise in the frontline brings clinical and educational value. J Glob Health. 2018;8:020414. doi: 10.7189/jogh.08.020414. PubMed DOI PMC
Biesecker LG, Green RC. Diagnostic clinical genome and exome sequencing. N Engl J Med. 2014;370:2418–2425. doi: 10.1056/NEJMra1312543. PubMed DOI